Global /United States /Healthcare /Medical Devices /SRTS
chevron_leftBack
Sensus Healthcare, Inc. logo

Sensus Healthcare, Inc.

SRTS
NASDAQ: SRTS Delayed
3.90USD 0.3%
As of 14 June 2026, Sensus Healthcare, Inc. has a market cap of $64.2M USD, ranking #28730 globally and #4288 in the United States. It ranks #2606 in the Healthcare sector, and #535 in the Medical Devices industry.
Global Rank
28730
Country Rank
4288
Sector Rank
2606
Industry Rank
535
Key Stats
Market Cap
$64.2MUSD
Enterprise Value
$42.43MUSD
Revenue (TTM)
$27.48MUSD
EBITDA (TTM)
-$9.92MUSD
Net Income (TTM)
-$7.72MUSD
EBITDA Margin
-36%
Profit Margin
-28%
PS Ratio
2.3
PB Ratio
1.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Joseph Sardano open_in_new
Employees
60
Founded
2010
IPO
03 Jun 2016
Website
sensushealthcare.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.3% -3.5% -0.5% -24% 19% -18%

News

Loading...

SRTS Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
SRTS
Sensus Healthcare Inc
ISIN: US81728J1097
Shares Out.:
16.462M1 Shares Float: 13.56M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
3.90 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Sensus Healthcare, Inc.

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
270K%
25.8
$160.73B
250K%
56.7
$159.07B
248K%
25.6
DHR
$126.55B
197K%
34.7
SYK
$120.69B
188K%
38.3
$84.93B
132K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
159K%
22.2
$97.46B
84.32B EUR
152K%
36.7
7741
$61.41B
9.83T JPY
96K%
40.0
$45.47B
39.34B EUR
71K%
18.7
ALC
$36.38B
28.99B CHF
57K%
37.9
$30.06B
203.66B CNY
47K%
26.0
chevron_leftBack